Trials / Completed
CompletedNCT00450554
Immunogenicity After Two Doses of Meningococcal Outer Membrane Vesicle Vaccine MenBVac
EVALUATION DE LA REPONSE IMMUNITAIRE CONTRE LA SOUCHE DE NEISSERIA MENINGITIDIS B:14,P1.7,16
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 236 (actual)
- Sponsor
- University Hospital, Rouen · Academic / Other
- Sex
- All
- Age
- 2 Years – 7 Years
- Healthy volunteers
- Accepted
Summary
The main objective of the study is to estimate the proportion of children, born between the 01/01/2002 and the 06/23/200, living around Dieppe (cantons Dieppe est, Dieppe Ouest and Offranville), vaccinated by MenBVac, with a serum bactericidal activity against B:14,P1-7,16 clone related to a protection (\>= 4), before and after the third MenBvac vaccination.
Conditions
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2007-03-22
- Last updated
- 2012-03-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00450554. Inclusion in this directory is not an endorsement.